While TB can be treated with the right medication, there are some big obstacles involved. One of the biggest is the increasing number of drug-resistant tuberculosis strains. That’s something researchers at Brock University in Ontario, Canada have been working to help with. With this goal in mind, they have developed microscopic nanobots capable of determining whether a blood sample not only contains the tuberculosis bacteria — but also bacteria with the necessary mutations to make it drug-resistant.

Read more at digitaltrends.com

Image Credit:   Brock University

News This Week

A chip to replace animal testing

New drugs made from nanoparticles that can easily penetrate any interface within our bodies are a great hope in medicine. For such hopefuls to reach the market, their safety must be ensured. In this [...]